Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

336.19
-3.1800-0.94%
Post-market: 336.190.00000.00%17:17 EST
Volume:1.38M
Turnover:466.88M
Market Cap:44.42B
PE:144.29
High:345.90
Open:336.58
Low:335.83
Close:339.37
52wk High:495.55
52wk Low:205.87
Shares:132.11M
Float Shares:126.15M
Volume Ratio:0.84
T/O Rate:1.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.33
EPS(LYR):2.33
ROE:73.28%
ROA:6.81%
PB:56.28
PE(LYR):144.29

Loading ...

Feb 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 12, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 12, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 13, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Dec 11, 2025

Major Issues Report

Form 8-K - Current report
Dec 03, 2025

Major Issues Report

Form 8-K - Current report
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 30, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2025

Major Issues Report

Form 8-K - Current report
Oct 03, 2025

Major Issues Report

Form 8-K - Current report
Oct 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 12, 2025

Major Issues Report

Form 8-K - Current report
Sep 10, 2025

Major Issues Report

Form 8-K - Current report
Sep 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities